Hypersensitivity pneumonitis (extrinsic allergic alveolitis)
Overview
Hypersensitivity pneumonitis (HP) / extrinsic allergic alveolitis (EAA) - inflammatory interstitial lung disease caused by immune response to inhaled organic antigens in a sensitised individual. Genuinely reversible if antigen removed early.
Presentation
Acute vs chronic HP
| Feature | Acute HP | Chronic HP |
|---|---|---|
| Onset | Symptoms 4-8 h after exposure | Insidious, months to years |
| Key symptoms | Dyspnoea, fever, chills, dry cough, myalgia | Progressive exertional dyspnoea, weight loss, fatigue |
| Examination | Often normal between episodes | Bilateral fine inspiratory crackles, digital clubbing (late) |
| Reversibility | Full recovery if antigen removed | Fibrosis largely irreversible |
Investigations
•Chest X-ray - bilateral diffuse infiltrates, upper/mid-zone predominance; normal CXR does not exclude HP
•HRCT thorax - ground-glass opacification, centrilobular nodules, mosaic attenuation (acute); honeycombing and traction bronchiectasis (chronic/fibrotic)
•Pulmonary function tests - restrictive pattern (reduced FEV1, FVC, preserved FEV1:FVC ratio) + reduced TLCO/DLCO
•Serum precipitins (antigen-specific IgG) - confirms sensitisation; positive in most exposed individuals but does NOT confirm disease
•Bronchoalveolar lavage (BAL) - hallmark: raised lymphocytes (lymphocytosis); inverted CD4:CD8 ratio (predominantly CD8+)
•Surgical lung biopsy (gold standard) - non-caseating granulomata with lymphocytic alveolitis; reserved for diagnostically uncertain cases
Differential diagnosis
Key differentials
| Condition | Distinguishing features |
|---|---|
| Sarcoidosis | Granulomatous disease but CD4:CD8 ratio elevated (not inverted); bilateral hilar lymphadenopathy; multi-system involvement |
| IPF | No identifiable allergen, no BAL lymphocytosis, no reversibility; chronic HP can mimic radiologically |
| Community-acquired pneumonia | Acute HP with fever mimics infection; key: temporal link to antigen exposure, no productive cough |
| Psittacosis | Chlamydia psittaci from birds; true pneumonia with relative bradycardia and splenomegaly; treat with doxycycline |
Management
🥇 First-line
•antigen removal - identify and eliminate causative agent; complete avoidance gives best prognosis; may require occupational change or environmental modification
•supplemental oxygen - for hypoxaemia in acute episodes; target SpO2 94-98%
🥈 Second-line
•oral prednisolone - if symptoms persist despite antigen removal; tapering course; accelerates resolution in acute disease
🥉 Third-line
•immunosuppressants - azathioprine or cyclophosphamide if inadequate corticosteroid response; under specialist guidance
•End-stage: lung transplantation assessment for progressive fibrotic disease
Pathophysiology and causes
•Type III (immune complex/IgG precipitins) + Type IV (T-cell granulomatous) hypersensitivity - dual mechanism
•Result: lymphocytic alveolitis with non-caseating granulomata → if persistent, irreversible fibrosis
Named condition | Antigen source |
Farmer's lung | Thermophilic actinomycetes (mouldy hay) |
Bird-fancier's lung | Avian proteins (pigeons, budgerigars) |
Malt worker's lung | Aspergillus clavatus (mouldy malt) |
Mushroom worker's lung | Thermophilic actinomycetes (compost) |
Hot tub lung | Mycobacterium avium complex (contaminated water) |
Prognosis and complications
•Acute HP - excellent prognosis with full recovery if antigen removed promptly
•Chronic fibrotic HP - substantially worse; may be indistinguishable from IPF; continued antigen exposure is the strongest predictor of poor outcome
•Complications: irreversible pulmonary fibrosis, type 1 respiratory failure, pulmonary hypertension, cor pulmonale